跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
复方氨林巴比妥注射液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Compound Aminophenazone and Barbital Injection
Approved
化学药品
Compound Aminophenazone and Barbital Injection
通化华夏药业有限责任公司
🇨🇳 National Medical Products Administration
Approval Date
Oct 26, 2023
Approval ID
7LeaffjSH4J
Company
通化华夏药业有限责任公司
Type
化学药品
Approval Details
Approval Id
7LeaffjSH4J
Approval Number
国药准字H22025918
Generic Name
复方氨林巴比妥注射液
Generic Name En
Compound Aminophenazone and Barbital Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
2ml:氨基比林0.1g,安替比林40mg,巴比妥18mg
Reg Date
2023-10-26
Company Name
通化华夏药业有限责任公司
Company Address
吉林省通化县快大茂镇黎明工业区
Production Company Name
通化华夏药业有限责任公司
Production Company Address
吉林省通化县快大茂镇黎明工业区
Company Detail Path
/organization/tong-hua-hua-xia-yao-ye-you-xian-ze-ren-gong-si
Production Company Detail Path
/organization/tong-hua-hua-xia-yao-ye-you-xian-ze-ren-gong-si
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 26, 2023
Approval ID
7LeaffjSH4J
Type
化学药品
Back to NMPA Approvals